|
Feature
|
Malignant lesions (mean ± standard deviation)
|
Benign lesions (mean ± standard deviation)
|
p value
|
AUC (95% confidence interval)
|
|---|
|
Entropy
|
5.28 ± 0.38
|
5.67 ± 0.16
|
< 0.00001 for all
|
0.86 (0.82–0.89)
|
|
Skewness
|
0.74 ± 0.33
|
0.54 ± 0.41
|
0.66 (0.61–0.70)
|
|
Kurtosis
|
0.53 ± 0.67
|
0.31 ± 0.66
|
0.61 (0.56–0.65)
|
|
Contrast
|
24.45 ± 10.61
|
28.40 ± 13.66
|
0.58 (0.53–0.63)
|
|
GLN (GLCM)
|
96.33 ± 87.47
|
60.58 ± 61.73
|
0.67 (0.62–0.71)
|
|
RLN (GLCM)
|
2,218.97 ± 1,834.77
|
1,523.25 ± 1,681.38
|
0.66 (0.62–0.71)
|
|
HGRE (GLCM)
|
1,163.54 ± 20.49
|
1,171.63 ± 19.35
|
0.62 (0.57–0.67)
|
|
SRHGE (GLCM)
|
1,067.79 ± 32.58
|
1,080.79 ± 29.69
|
0.63 (0.58–0.67)
|
|
GLN (GLRLM)
|
96.43 ± 87.45
|
60.70 ± 61.72
|
0.67 (0.62–0.71)
|
|
RLN (GLRLM)
|
2,218.89 ± 1,828.26
|
1,525.31 ± 1,677.17
|
0.67 (0.62–0.71)
|
|
HGRE (GLRLM)
|
1,165.00 ± 20.59
|
1,173.06 ± 19.57
|
0.62 (0.57–0.67)
|
|
SRHGE (GLRLM)
|
1,069.20 ± 33.13
|
1,082.28 ± 29.75
|
0.62 (0.58–0.67)
|
- GLN Grey-level non-uniformity, GLCM Grey-level co-occurrence matrix, RLN Run length non-uniformity, HGRE High grey-level run emphasis, SRHGE Short-run high grey-level emphasis, GLN Grey-level non-uniformity, GLRLM Grey-level run length matrix
